Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Research Protocols

Date Submitted: Nov 13, 2019
Date Accepted: Jan 24, 2020

The final, peer-reviewed published version of this preprint can be found here:

The Scleroderma Patient-Centered Intervention Network Self-Management Program: Protocol for a Randomized Feasibility Trial

Carrier ME, Kwakkenbos L, Nielson WR, Fedoruk C, Nielsen K, Milette K, Pope J, Frech T, Gholizadeh S, Hummers L, Johnson SR, Piotrowski P, Jewett L, Gordon J, Chung L, Bilsker D, Turner KA, Cumin J, Welling J, Fortune C, Leite C, Gottesman K, Sauve M, Rodriguez Reyna TS, Hudson M, Larche M, Van Breda W, Suarez-Almazor ME, Bartlett SJ, Malcarne VL, Mayes MD, Boutron I, Mouthon L, Wigley F, Thombs BD, SPIN Investigators

The Scleroderma Patient-Centered Intervention Network Self-Management Program: Protocol for a Randomized Feasibility Trial

JMIR Res Protoc 2020;9(4):e16799

DOI: 10.2196/16799

PMID: 32329747

PMCID: 7210498

Protocol for a Randomized Feasibility Trial of the Scleroderma Patient-centered Intervention Network Self-Management (SPIN-SELF) Program

  • Marie-Eve Carrier; 
  • Linda Kwakkenbos; 
  • Warren R. Nielson; 
  • Claire Fedoruk; 
  • Karen Nielsen; 
  • Katherine Milette; 
  • Janet Pope; 
  • Tracy Frech; 
  • Shadi Gholizadeh; 
  • Laura Hummers; 
  • Sindhu R. Johnson; 
  • Pamela Piotrowski; 
  • Lisa Jewett; 
  • Jessica Gordon; 
  • Lorinda Chung; 
  • Dan Bilsker; 
  • Kimberly A. Turner; 
  • Julie Cumin; 
  • Joep Welling; 
  • Catherine Fortune; 
  • Catarina Leite; 
  • Karen Gottesman; 
  • Maureen Sauve; 
  • Tatiana Sofia Rodriguez Reyna; 
  • Marie Hudson; 
  • Maggie Larche; 
  • Ward Van Breda; 
  • Maria E. Suarez-Almazor; 
  • Susan J. Bartlett; 
  • Vanessa L. Malcarne; 
  • Maureen D. Mayes; 
  • Isabelle Boutron; 
  • Luc Mouthon; 
  • Fredrick Wigley; 
  • Brett D. Thombs; 
  • SPIN Investigators

ABSTRACT

Background:

Systemic sclerosis (SSc), or scleroderma, is a rare disease that often results in significant disruptions to activities of daily living and can negatively affect physical and psychological well-being. Because there is no known cure, SSc treatment focuses on reducing symptoms and disability and improving health-related quality of life (HRQL). Self-management programs are known to increase self-efficacy for disease management in many chronic diseases. The Scleroderma Patient-centered Intervention Network (SPIN) developed an online self-management program (SPIN-SELF) to increase self-efficacy for disease management and to improve HRQL for SSc patients.

Objective:

The aim of the proposed study is to assess the feasibility of conducting a full-scale randomized controlled trial (RCT) of the SPIN-SELF program, by evaluating the trial implementation processes, required resources and management, scientific aspects, and participant acceptability and usage of the SPIN-SELF program.

Methods:

The SPIN-SELF feasibility trial will be conducted via the SPIN Cohort. The SPIN Cohort was developed as a framework for embedded pragmatic trials using the cohort multiple RCT design. In total, 40 English-speaking SPIN Cohort participants with low disease-management self-efficacy (Self-Efficacy for Managing Chronic Disease Scale score ≤ 7) who have indicated interest in using an online self-management program will be randomized with a 3:2 ratio to be offered the SPIN-SELF program or usual care for 3 months.

Results:

Feasibility outcomes include trial implementation processes, required resources and management, scientific aspects, and patient acceptability and usage of the SPIN-SELF program.

Conclusions:

The SPIN-SELF program is a self-help tool that may improve disease-management self-efficacy and improve HRQL in patients with SSc. The SPIN-SELF feasibility trial will ensure that trial methodology is robust, feasible, and consistent with trial participant expectations. The results will guide adjustments that need to be implemented before undertaking a full-scale RCT of the SPIN-SELF program. Clinical Trial: NCT03914781


 Citation

Please cite as:

Carrier ME, Kwakkenbos L, Nielson WR, Fedoruk C, Nielsen K, Milette K, Pope J, Frech T, Gholizadeh S, Hummers L, Johnson SR, Piotrowski P, Jewett L, Gordon J, Chung L, Bilsker D, Turner KA, Cumin J, Welling J, Fortune C, Leite C, Gottesman K, Sauve M, Rodriguez Reyna TS, Hudson M, Larche M, Van Breda W, Suarez-Almazor ME, Bartlett SJ, Malcarne VL, Mayes MD, Boutron I, Mouthon L, Wigley F, Thombs BD, SPIN Investigators

The Scleroderma Patient-Centered Intervention Network Self-Management Program: Protocol for a Randomized Feasibility Trial

JMIR Res Protoc 2020;9(4):e16799

DOI: 10.2196/16799

PMID: 32329747

PMCID: 7210498

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.